Recombinant adeno-associated virus 9-mediated expression of Kallistatin suppresses lung tumor growth in mice.

CONCLUSION: The results indicate that this therapeutic strategy is a promising approach for clinical cancer therapy and impli-cate rAAV9-Kal as a candidate for gene therapy of lung cancer. PMID: 33183200 [PubMed - as supplied by publisher]
Source: Current Gene Therapy - Category: Genetics & Stem Cells Authors: Tags: Curr Gene Ther Source Type: research